Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
American Journal of Physiology. Renal Physiology|July 20, 2012
VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult miceSebastian Oltean, Christopher R Neal, Athina Mavrou, et al.Scientific Reports|April 13, 2021
CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancerSimon Uzor, Sean R Porazinski, Ling Li, et al.Molecular Cancer Research : MCR|June 14, 2011
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markersAndrew J Armstrong, Matthew S Marengo, Sebastian Oltean, et al.Plos One|August 13, 2013
Detection of VEGF-A(xxx)b isoforms in human tissuesDavid O Bates, Athina Mavrou, Yan Qiu, et al.Journal of the American Society of Nephrology : JASN|December 28, 2014
Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic NephropathySebastian Oltean, Yan Qiu, Joanne K Ferguson, et al.Journal of the American Society of Nephrology : JASN|August 7, 2010
Overexpression of VEGF165b in podocytes reduces glomerular permeabilityYan Qiu, Joanne Ferguson, Sebastian Oltean, et al.British Journal of Cancer|June 26, 2020
Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancerLing Li, Lisa Hobson, Laura Perry, et al.Molecular Oncology|September 14, 2021
The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressorDanny Legge, Ling Li, Whei Moriarty, et al.Molecular Oncology|August 12, 2024
Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumorsMegan Stevens, Yuanli Wang, Stephanie J Bouley, et al.Comprehensive Physiology|July 7, 2018
Physiological Role of Vascular Endothelial Growth Factors as Homeostatic RegulatorsDavid O Bates, Nicholas Beazley-Long, Andrew V Benest, et al.Pageof 6